Grand River Aseptic Manufacturing (GRAM) recently executed two commercial production contracts on the same day.

The first contract signed is with a medium-sized publicly-held pharmaceuticals company and the second contract is with a multi-billion dollar biopharmaceuticals company.

“Our team invests a great deal of time and effort in working with new customers to develop tailored strategies to ensure successful projects. It was incredibly rewarding to see both of the new customer contracts come to fruition on the same day,” said GRAM business development manager April Ladd.

Tom Ross, GRAM president, added, “We are excited to get started on the work for both of these companies and keep the momentum going into the New Year. To have won these contracts shows the commitment GRAM has made to quality and operational excellence. Our customers feel secure bringing their products to our fill/finish facilities and know they’re in good hands with our experienced Operations and Quality teams.”

GRAM is a parenteral contract manufacturing organization supporting clinical through commercial cGMP manufacturing. With a state-of-the-art cleanroom GRAM provides clinical trial and commercial material in vials or syringes for the life sciences industry.

GRAM specializes in pre-clinical, clinical, and commercial manufacturing and offers the following services: sterile product development and manufacture, lyophilization, terminal sterilization and analytical and microbiological testing, stability sample storage, labeling and packaging storage and distribution.